#lundbeck — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #lundbeck, aggregated by home.social.
-
https://www.europesays.com/es/570234/ Impulso de la neurociencia mediante el uso de la IA: de leer la actividad cerebral a interactuar dinámicamente con el cerebro #A1 #ES #España #Health #InteligenciaArtificial #laboratorio #lundbeck #neurociencia #Salud #Spain
-
Lundbeck Reports 2025 Financial Results
Total revenue increased 13% CER to DKK 24,630 million, supported by US (+21% CER) and Europe (+13% CER) sales. Adjusted EBITDA rose 24% CER. Strategic brands, including Rexulti and Brintellix/Trintellix, grew 19% CER to DKK 19,011 million, accounting for 77% of total revenue.
-
Lundbeck Reports 2025 Financial Results
Total revenue increased 13% CER to DKK 24,630 million, supported by US (+21% CER) and Europe (+13% CER) sales. Adjusted EBITDA rose 24% CER. Strategic brands, including Rexulti and Brintellix/Trintellix, grew 19% CER to DKK 19,011 million, accounting for 77% of total revenue.
-
Lundbeck Reports 2025 Financial Results
Total revenue increased 13% CER to DKK 24,630 million, supported by US (+21% CER) and Europe (+13% CER) sales. Adjusted EBITDA rose 24% CER. Strategic brands, including Rexulti and Brintellix/Trintellix, grew 19% CER to DKK 19,011 million, accounting for 77% of total revenue.
-
Lundbeck Reports 2025 Financial Results
Total revenue increased 13% CER to DKK 24,630 million, supported by US (+21% CER) and Europe (+13% CER) sales. Adjusted EBITDA rose 24% CER. Strategic brands, including Rexulti and Brintellix/Trintellix, grew 19% CER to DKK 19,011 million, accounting for 77% of total revenue.
-
Lundbeck Reports 2025 Financial Results
Total revenue increased 13% CER to DKK 24,630 million, supported by US (+21% CER) and Europe (+13% CER) sales. Adjusted EBITDA rose 24% CER. Strategic brands, including Rexulti and Brintellix/Trintellix, grew 19% CER to DKK 19,011 million, accounting for 77% of total revenue.
-
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
#NewsBeep #News #Medication #advisorycommittee #AU #Australia #clinicaltrials #Drugcombinationtherapy #FDA #FDArejection #Health #Lundbeck #OtsukaPharmaceutical #pharma #psychiatricmedications #PTSDtreatment #Rexulti #Zoloft
https://www.newsbeep.com/au/162207/ -
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
#NewsBeep #News #Medication #advisorycommittee #CA #Canada #clinicaltrials #Drugcombinationtherapy #FDA #FDArejection #Health #Lundbeck #OtsukaPharmaceutical #Pharma #psychiatricmedications #PTSDtreatment #Rexulti #Zoloft
https://www.newsbeep.com/ca/162519/ -
Diabetes tech: a catalyst rich sector with a dazzling future — Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record --Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications -- See more on our front page news http://bit.ly/w28kSd #diabetes #medtech #ada #lundbeck #pharmaceos #sanofi #eczema #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Diabetes tech: a catalyst rich sector with a dazzling future — Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record --Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications -- See more on our front page news http://bit.ly/w28kSd #diabetes #medtech #ada #lundbeck #pharmaceos #sanofi #eczema #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma